IS Pharma, the international speciality pharmaceutical company, has raised £3.6 million through the issue of shares at 77p through a placing with Abingworth LLP. The placing price was at a 9% premium to the closing price of 70.5p on the 5 October 2010. Abingworth will now be IS Pharma’s largest shareholder with c. 13% of the shares in issue.

IS Pharma also announced that the Company intends to introduce a maiden dividend for the year ending 31 March 2011.

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here